Home» Circulars» Viewcirculars Back
Whitepaper on Pharma landscape in New Zealand


PXL/HO/Cir-022/2022-23                                                                    Date:  20.06.2022




Dear Sir / Madam,


Subject: Whitepaper on Pharma landscape in New Zealand.


We are pleased to inform our members that the Indian High Commission to New Zealand has published a whitepaper on “Health and Pharmaceutical Landscape of New Zealand”  with the valuable collaboration of India-New Zealand Business Council (INZBC) as a research partner. This report is a comprehensive guide on how the pharmaceutical industry works in New Zealand.


In the year 2021, New Zealand imported NZ$ 91.03 million of pharmaceutical products from India, representing 2.3% of total imports of pharmaceutical products. There is a huge potential for growth in bilateral trade in the pharmaceutical sector considering the fact that India enjoys an important position in the global supply.


Members are aware that the New Zealand pharma landscape is regulated under the regime of Pharmac. This manual is a sincere effort to put together relevant details relating to steps to be taken for exporting medicines to New Zealand and listing of relevant organizations. The report also gives important contact details of key stakeholders in New Zealand. This publication is an all-in-one guide for all stakeholders in the Pharma sector in India who desire to trade with New Zealand. This detailed REPORTis enclosed for your ready reference.



With regards,




Uday Bhaskar

Director General


Encl.: Report on Health and Pharmaceutical Landscape of New Zealand